JNPA and UPSIDA Sign MoU to Turn Lalitpur Pharma Park Into a Global Export Hub

In a move that could reshape pharmaceutical export logistics in northern India, the Jawaharlal Nehru Port Authority (JNPA) and the Uttar Pradesh State Industrial Development Authority (UPSIDA) have signed a landmark memorandum of understanding aimed at positioning the proposed Lalitpur Pharma Park as a world-class global export destination. The MoU was formally signed by UPSIDA Chief Executive Officer Vijay Kiran Anand and JNPA Chairman Gaurav Dayal. The agreement is designed to create a seamless logistics corridor connecting the industrial heartland of northern India to international markets, according to an official statement released by UPSIDA. At its core, the strategic partnership seeks to directly link the Lalitpur Pharma Park to global maritime trade routes — a development that officials describe as a transformative milestone in the region's industrial trajectory. The collaboration is expected to give pharmaceutical manufacturers based at the park direct access to some of the world's most active shipping lanes, dramatically improving their ability to compete in international markets. Speaking about the significance of the agreement, UPSIDA